NEXTCURE, INC Other Non-Current Assets
NEXTCURE, INC (NXTC) had Other Non-Current Assets of $82.00 thousand as of 2026-06-30, per its S-4 filed 2026-08-18.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OtherAssetsNoncurrent · last filed 2026-08-18
- 2026-06-30: Other Assets, Noncurrent $82.00K.
- 2026-03-31: Other Assets, Noncurrent $847.00K.
- 2025-12-31: Other Assets, Noncurrent $546.00K.
- 2025-09-30: Other Assets, Noncurrent $550.00K.
| Period end | Other Assets, Noncurrent |
|---|---|
| 2026-06-30 | $82.00K S-4 · filed 2026-08-18 |
| 2026-03-31 | $847.00K 10-Q · filed 2026-05-07 |
| 2025-12-31 | $546.00K S-4 · filed 2026-08-18 |
| 2025-09-30 | $550.00K 10-Q · filed 2025-11-05 |
| 2025-06-30 | $555.00K 10-Q · filed 2025-08-07 |
| 2025-03-31 | $328.00K 10-Q · filed 2025-05-01 |
| 2024-12-31 | $332.00K S-4 · filed 2026-08-18 |
| 2024-09-30 | $2.07M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $1.87M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $1.88M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $1.88M 10-K · filed 2025-03-06 |
| 2023-09-30 | $2.85M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $2.86M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $2.82M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $3.27M 10-K · filed 2024-03-21 |
| 2022-09-30 | $2.47M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $801.00K 10-Q · filed 2022-08-04 |
| 2022-03-31 | $574.00K 10-Q · filed 2022-05-05 |
| 2021-12-31 | $577.00K 10-K · filed 2023-03-02 |
| 2021-09-30 | $581.00K 10-Q · filed 2021-11-04 |
| 2021-06-30 | $2.02M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $2.44M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $2.86M 10-K · filed 2022-03-03 |
| 2020-09-30 | $3.28M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $3.59M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $4.02M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $4.08M 10-K · filed 2021-03-04 |
| 2019-09-30 | $3.94M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $4.20M 10-Q · filed 2019-08-12 |
| 2019-03-31 | $2.01M 10-Q · filed 2019-06-10 |
| 2018-12-31 | $436.00K 10-K · filed 2020-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |